Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: A post hoc analysis

European Journal of Neurology

Volumn 21, Issue 10, 2014, Pages 1311-1317

  Davidai, G ^a   Cotton, D ^a   Gorelick, P ^b   Bath, P M W ^c   Lipton, R B ^d   Sacco, R ^e   Diener, H C ^f  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cerebrovascular disease; Dipyridamole; Headache; Intracerebral hemorrhage; Stroke; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; CLOPIDOGREL; DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; DELAYED RELEASE FORMULATION;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SECONDARY PREVENTION; TREATMENT DURATION; CHEMICALLY INDUCED; DELAYED RELEASE FORMULATION; DRUG COMBINATION; HEADACHE; MIDDLE AGED; RISK; STROKE; TREATMENT OUTCOME;

AGED; ASPIRIN; BRAIN ISCHEMIA; DELAYED-ACTION PREPARATIONS; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RISK; SECONDARY PREVENTION; STROKE; TREATMENT OUTCOME;

EID: 84908661465     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12484     Document Type: Article

References (23)

1. Diener HC, Cuhna L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
2. The ESPRIT Study Group, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665-1673.
3. Sacco R, Diener H, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008; 359: 1238-1251.
4. Diener HC, Forbes C, Riekkinen PJ, et al. European Stroke Prevention Study 2: efficacy and safety data. J Neurol Sci 1997; 151: S1-S77.
5. ESPS-2 Working Group. Second European Stroke Prevention Study. J Neurol 1992; 239: 299-301.
6. Bertrand-Hardy JM, Cunha L, Forbes C, et al. European Stroke Prevention Study 2: baseline data. J Neurol Sci 1995; 131(Suppl): 1-58.
7. Asghar MS, Hansen AE, Amin FM, et al. Evidence for a vascular factor in migraine. Ann Neurol 2011; 69: 635-645.
8. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991; 338: 13-17.
9. Amin FM, Asghar MS, Hougaard A, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol 2013; 12: 454-461.
10. Schoonman GG, van der Grond J, Kortmann C, van der Geest RJ, Terwindt GM, Ferrari MD. Migraine headache is not associated with cerebral or meningeal vasodilatation - a 3T magnetic resonance angiography study. Brain 2008; 131: 2192-2200.
11. Kruuse C, Jacobsen TB, Lassen LH, et al. Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects. J Cereb Blood Flow Metab 2000; 20: 1372-1379.
12. Kruuse C, Lassen LH, Iversen HK, Oestergaard S, Olesen J. Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 2006; 26: 925-933.
13. Eisert WG. Dipyridamole. In: Michelson AD, ed. Platelets, 2nd edn. Academic Press: Burlington, MA, 2007: 1165-1179.
14. Kim HH, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol 2008; 28: s39-s42.
15. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 2008; 120: 157-171.
16. Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 2003; 126: 241-247.
17. Gamboa A, Abraham R, Diedrich A, et al. Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole. Stroke 2005; 36: 2170-2175.
18. Birk S, Petersen KA, Kruuse C, et al. The effect of circulating adenosine on cerebral haemodynamics and headache generation in healthy subjects. Cephalalgia 2005; 25: 369-377.
19. Guieu R, Devaux C, Henry H, et al. Adenosine and migraine. Can J Neurol Sci 1998; 25: 55-58.
20. Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011; 9: 120-138.
21. Chakrabarti S, Vitseva O, Iyu D, Varghese S, Freedman JE. The effect of dipyridamole on vascular cell-derived reactive oxygen species. J Pharmacol Exp Ther 2005; 315: 494-500.
22. Chakrabarti S, Freedman JE. Dipyridamole, cerebrovascular disease, and the vasculature. Vascul Pharmacol 2008; 48: 143-149.
23. Guo S, Stins M, Ning M, Lo EH. Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells. Cerebrovasc Dis 2010; 30: 290-296.